NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
April 21, 2026
Silo Wellness Secures Right of First Refusal on All Psilocybin Mushroom Biomass from Medford, Oregon First-Mover Satya; Other Corporate Updates
March 24, 2023
Related Post
-
-
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
April 17, 2026
-
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
April 16, 2026
-
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
April 15, 2026